Rapport Therapeutics, Inc. Common Stock (RAPP) Insider Trading

Over the last 3 months, RAPP insiders made 0 open-market buys and 10 sales, a net sale of -$35.9M (SEC Form 4). Over the last 6 months, 109 institutions increased and 68 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$35.9M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +33.2%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 10, 2026PAUL STEVEN MdirectorGrant15,200$35.21
Jun 10, 2026PEREZ ROBERT JdirectorGrant15,200$35.21
Jun 10, 2026MARAGANORE JOHNdirectorGrant15,200$35.21
Jun 10, 2026Sanchez RamirodirectorGrant15,200$35.21
Jun 10, 2026Young Wendy B.directorGrant15,200$35.21
Jun 10, 2026Huber Reid MdirectorGrant15,200$35.21
Jun 10, 2026HEALY JAMESdirectorGrant15,200$35.21
Jun 10, 2026Silva Paul MdirectorGrant15,200$35.21
May 28, 2026Third Rock Ventures V, L.P.10 percent ownerSell18,572$40.05
May 13, 2026Third Rock Ventures V, L.P.10 percent ownerSell133,618$40.24
May 11, 2026Third Rock Ventures V, L.P.10 percent ownerSell5,018$40.31
May 11, 2026Third Rock Ventures V, L.P.10 percent ownerSell271,495$40.12
Apr 21, 2026Third Rock Ventures V, L.P.10 percent ownerSell426,005$40.32
Apr 21, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell20,225$39.99
Apr 14, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell9,165$34.97
Apr 14, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell500$34.98
Apr 14, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell10,200$35.08
Apr 9, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell360$34.90
Mar 31, 2026Gault Cherylofficer: Chief Operating OfficerSell2,839$28.55
Mar 31, 2026Gault Cherylofficer: Chief Operating OfficerSell7,161$28.04
Mar 26, 2026Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell10,115$29.99
Mar 9, 2026Gault Cherylofficer: Chief Operating OfficerSell2,014$28.93
Feb 19, 2026Bredt Davidofficer: Chief Scientific OfficerSell900$28.02
Feb 19, 2026Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,983$29.04
Feb 19, 2026Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,281$29.80
Feb 19, 2026Ceesay Abrahamdirector, officer: Chief Executive OfficerSell3,552$29.05
Feb 19, 2026Bredt Davidofficer: Chief Scientific OfficerSell5,400$28.95
Feb 19, 2026Bredt Davidofficer: Chief Scientific OfficerSell2,200$29.59
Feb 19, 2026Bredt Davidofficer: Chief Scientific OfficerOption6,000$1.80
Feb 19, 2026Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,100$29.80

Source: RAPP SEC Form 4 filings, latest Jun 10, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their RAPP positions over the last 6 months (SEC Form 13F).

Increased
109
New positions
67
Reduced
68
Sold out
44
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased7.2MMay 15, 2026
TRV GP V, LLCUnchanged7.1MFeb 13, 2026
TRV GP V, LLCUnchanged7.1MMay 7, 2026
FMR LLCIncreased7.1MFeb 17, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged3.7MFeb 17, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged3.7MMay 15, 2026
CAPITAL INTERNATIONAL INVESTORSUnchanged3.4MFeb 11, 2026
CAPITAL INTERNATIONAL INVESTORSReduced3.1MMay 13, 2026
CORMORANT ASSET MANAGEMENT, LPReduced3.0MFeb 17, 2026
GOLDMAN SACHS GROUP INCIncreased3.0MMar 25, 2026
CORMORANT ASSET MANAGEMENT, LPReduced3.0MMay 15, 2026
GOLDMAN SACHS GROUP INCReduced2.9MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2.7MMay 15, 2026
BLACKROCK, INC.Increased2.5MMay 13, 2026
BLACKROCK, INC.Increased2.4MFeb 12, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.